Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Transcatheter mitral valve therapies / / Ron Waksman, Toby Rogers
| Transcatheter mitral valve therapies / / Ron Waksman, Toby Rogers |
| Autore | Waksman Ron |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : John Wiley & Sons, Inc., , [2021] |
| Descrizione fisica | 1 online resource (403 pages) |
| Disciplina | 617.412 |
| Soggetto topico | Mitral valve - Surgery |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-119-76374-6
1-119-49065-0 1-119-49067-7 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Title Page -- Copyright Page -- Contents -- List of Contributors -- Introduction-The Mitral Book -- Chapter 1 The Pathology of Mitral Valve Disease -- 1.1 Introduction -- 1.2 General Anatomy of the Mitral Valve -- 1.2.1 Mitral Annulus -- 1.2.2 Leaflets -- 1.2.3 Chordae Tendineae and Papillary Muscles -- 1.2.4 Papillary Muscles and Left Ventricle -- 1.3 Pathology of Mitral Valve -- 1.3.1 Mitral Valve Stenosis -- 1.3.2 Aging Changes and Mitral Annulus Calcification (MAC) -- 1.3.3 Acute Mitral Regurgitation -- 1.3.4 Chronic Mitral Regurgitation -- 1.3.5 Degenerative MR -- Myxomatous Degeneration of the Mitral Valve -- 1.3.6 Functional MR -- References -- Chapter 2 The Importance of Minimally Invasive Approaches for Mitral Valve Repair -- 2.1 Introduction to Minimally Invasive Mitral Valve Surgery -- 2.2 The Importance of MICS MVS -- 2.3 Patient Selection -- 2.4 Surgical Setup-Fibrillating Heart MVS -- 2.5 Alternatives for Cannulation -- 2.6 Alternatives to Myocardial Protection -- 2.7 Mitral Valve Repair -- 2.8 Outcomes -- 2.9 Initiating Minimally Invasive Mitral Valve Repair Program -- 2.10 Conclusion -- References -- Chapter 3 When to Intervene-Should Surgical Guidelines Apply to Transcatheter Techniques in Treating Mitral Regurgitation? -- 3.1 Introduction -- 3.2 Primary MR -- 3.2.1 Current Guideline Recommendations -- 3.2.2 Transcatheter Therapies-New Guideline Applications? -- 3.3 Secondary MR -- 3.3.1 Current Guideline Recommendations -- 3.4 Conclusions -- References -- Chapter 4 Transcatheter Mitral Valve Therapies: A Three-Dimensional Echocardiographic View -- 4.1 Introduction -- 4.1.1 Mitral Valve Anatomy -- 4.1.2 Mitral Valve Structure and Function -- 4.1.3 Mitral Regurgitation Severity -- 4.1.4 Diagnosis of MR Severity: Proximal Isovelocity Surface Area Method -- 4.1.5 Diagnosis of MR Severity: Vena Contracta Method.
4.1.6 Primary and Secondary MR -- 4.1.7 Mitral Regurgitation and Cardiovascular Death and Morbidity -- 4.1.8 Screening for MitraClip Suitability -- 4.1.9 MitraClip Procedure Guidance -- 4.1.10 Transseptal Puncture -- 4.1.11 MitraClip Delivery Guidance -- 4.1.12 Adequacy of MitraClip Implantation Assessment -- 4.1.13 Other Technologies -- 4.2 Conclusions -- References -- Chapter 5 CMR Assessment of Mitral Regurgitation -- 5.1 Introduction -- 5.2 Pulse Sequences Used in CMR -- 5.2.1 Cine Imaging -- 5.2.2 Phase Contrast Imaging -- 5.3 Assessment of MR Severity -- 5.3.1 Qualitative Assessment -- 5.3.2 Quantitative Assessment -- 5.3.3 Technical Considerations for the Quantitative Assessment of MR by CMR -- 5.4 Identification of MR Etiology -- 5.4.1 Primary MR -- 5.4.2 Secondary MR -- 5.5 The Role of CMR Assessment of MR in Clinical Practice -- 5.6 Conclusions -- References -- Chapter 6 CT Planning for TMVR and Predicting LVOT Obstruction -- 6.1 Introduction -- 6.2 History of Imaging for Mitral Valve Disease -- 6.2.1 TAVR CT Planning -- 6.2.2 Surgical and Transcatheter Mitral Interventions -- 6.3 Concept of Aortic and Mitral Valve Technology Development -- 6.4 Basics of CT Imaging Acquisition -- 6.5 Definition of Mitral Valve and TMVR device Landing Zone -- 6.6 Definition of LVOT -- 6.7 CT Methods for Neo-LVOT prediction modeling -- 6.8 CT Validation of Neo-LVOT Prediction Modeling Post-TMVR -- 6.9 Correlation Between Pre- and Post-TMVR CT Neo-LVOT Prediction Modeling -- 6.10 What Else Has CT Planning for TMVR Taught Us? -- Acknowledgments -- References -- Chapter 7 General Principles and State-of-the-Art Echocardiographic Evaluation of the Mitral Valve -- 7.1 Introduction -- 7.2 Mechanism and Etiology of Chronic MR -- 7.2.1 Transthoracic Echocardiography -- 7.2.2.1 Color Flow Doppler -- 7.2.2 Qualitative Assessment -- 7.2.2.1 Color Flow Doppler. 7.3 Continuous Wave (CW) Density Jet -- 7.3.1 Semi-Quantitative Assessment -- 7.3.1.1 VC Width -- 7.4 Pulmonary Vein Flow/Mitral Inflow -- 7.4.1 Quantitative Assessment -- 7.5 Selection of Best Candidates for Interventions of the Mitral Valve -- 7.5.1 Echocardiographic Criteria of COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation) Trial -- References -- Chapter 8 Intraprocedural Echocardiography for MitraClip -- 8.1 Introduction -- 8.2 Pre-Procedure Evaluation -- 8.3 Importance of the Baseline Study - TEE -- 8.4 The Transseptal Puncture -- 8.5 Guiding MitraClip System to Mitral Valve -- 8.6 Intraprocedural Guidance of Clip within Mitral Valve and Leaflets -- 8.7 Post-Clip-Deployment Assessment of Mitral Valve Function -- 8.8 Assessment of Complications and Iatrogenic ASD -- References -- Chapter 9 Intraprocedural Echocardiography for Transcatheter Mitral Valve Replacement -- 9.1 Introduction -- 9.2 Baseline Mitral Valve Assessment -- 9.3 Access to the Left Atrium, Left Ventricle, and Mitral Valve -- 9.4 Predeployment and Deployment Monitoring -- 9.5 Postdeployment Evaluation -- References -- Chapter 10 Transcatheter Repair: MitraClip for Degenerative Mitral Regurgitation -- 10.1 Surgery for Degenerative Mitral Regurgitation -- 10.2 Evidence Base for MitraClip -- 10.3 Challenges for the MitraClip Procedure -- 10.4 Evaluation of MitraClip for Less than Prohibitive-Risk DMR Patients -- 10.5 Future Directions for MitraClip and Alternative Approaches for Leaflet Repair -- 10.6 Summary -- References -- Chapter 11 MitraClip™ for Secondary Mitral Regurgitation -- 11.1 Introduction -- 11.2 European and US Clinical Practice Guidelines -- 11.3 The MitraClip System -- 11.4 MitraClip Preprocedural Planning -- 11.5 Surgical Outcomes Data. 11.6 The COAPT and MITRA-FR Trials -- 11.7 Summary and Conclusions -- References -- Chapter 12 The Edwards PASCAL Transcatheter Valve Repair System -- 12.1 Introduction -- 12.2 The Edwards PASCAL™ Transcatheter Valve Repair System -- 12.3 Implantation Procedure -- 12.4 Compassionate-Use and Early Feasibility Data -- 12.5 Future Developments -- References -- Chapter 13 The Development of a Novel Percutaneous Treatment for Secondary Mitral Regurgitation-The Carillon® Mitral Contour System® -- 13.1 Introduction -- 13.2 REDUCE-FMR -- 13.3 The CARILLON Trial -- 13.4 Summary -- References -- Chapter 14 A Fully Percutaneous Mitral Ring: The Cardioband System -- 14.1 Introduction -- 14.2 Mitral Annulus Anatomy -- 14.3 Pathophysiological Role of the Mitral Annulus in Mitral Regurgitation -- 14.3.1 Mitral Annulus in FMR -- 14.3.2 Mitral Annulus in DMR -- 14.4 Surgical Annuloplasty in Mitral Regurgitation -- 14.5 The Cardioband System: Description of the Device -- 14.6 Procedural Planning -- 14.7 Clinical Studies -- 14.8 Possible Complications Related to the Implantation of Cardioband -- 14.9 Recurrence of Mitral Regurgitation Following Cardioband Implantation -- 14.10 Cardioband in Combination with Other Devices -- 14.11 Conclusions -- References -- Chapter 15 Transcatheter Mitral Cerclage Annuloplasty -- 15.1 Introduction -- 15.2 Cerclage Anatomy and Function -- 15.3 Limitations of Coronary Sinus Annuloplasty -- 15.4 Cerclage Annuloplasty Device -- 15.5 The Cerclage Procedure -- 15.6 Preclinical Experiments -- 15.7 Initial Human Experience -- 15.8 Future Directions -- 15.9 Summary -- Competing Interests -- References -- Chapter 16 The Transapical Off-Pump Mitral Valve Repair with the NeoChord Implantation (TOP-MINI) -- 16.1 Introduction -- 16.2 Technology -- 16.3 Patient Selection -- 16.4 Procedure -- 16.5 Echocardiographic Guidance -- 16.6 Examples. 16.6.1 Ideal Anatomy -- 16.6.2 Acceptable Anatomy -- 16.6.3 Challenging Anatomy -- 16.6.4 Data -- 16.7 Conclusion -- References -- Chapter 17 AltaValve™-A Transcatheter Mitral Valve Regurgitation Treatment Technology -- 17.1 Clinical Need -- 17.2 Device Description -- 17.2.1 Principle of Operation -- 17.2.2 Device Construction -- 17.2.2.1 Stent -- 17.2.2.2 Stent Cap -- 17.2.2.3 Tissue Valve -- 17.2.2.4 Fabric Skirts and Sutures -- 17.2.3 Delivery Systems -- 17.3 Anatomical Imaging and Sizing -- 17.4 Preclinical and Clinical Experience -- 17.4.1 Animal Studies -- 17.5 Human Clinical Experience -- 17.6 Summary -- References -- Chapter 18 The ARTO Transcatheter Mitral Valve Repair System -- 18.1 Device Description -- 18.2 Procedural Details -- 18.3 Clinical Experience with the ARTO System -- 18.4 Unique Features of the ARTO System -- References -- Chapter 19 Transcatheter Mitral Annuloplasty: The Millipede Device -- 19.1 Background -- 19.2 The Millipede Device -- 19.3 Millipede Implantation Procedure -- 19.4 Surgical Millipede Implants -- 19.5 Millipede Clinical Results -- 19.6 Clinical Implications -- 19.7 Summary -- Author Disclosures -- References -- Chapter 20 Transapical and Transseptal Access for Transcatheter Mitral Valve Replacement: Techniques and Devices -- 20.1 Introduction -- 20.2 Transapical Approach -- 20.2.1 Technique -- 20.2.2 Devices in Active Clinical Trial Phase -- 20.2.2.1 Tendyne -- 20.2.2.2 Intrepid -- 20.2.2.3 CardiAQ -- 20.2.2.4 TIARA -- 20.2.2.5 HighLife -- 20.3 Transseptal Approach -- 20.3.1 Technique -- 20.3.2 Devices in Active Clinical Trial Phase -- 20.3.2.1 Sapien M3 -- 20.3.2.2 EVOQUE -- 20.3.2.3 Caisson -- 20.4 Conclusions -- References -- Chapter 21 Mitral Valve-in-Valve and Valve-in-Ring Therapies -- 21.1 Overview -- 21.2 Evidence -- 21.3 Procedure Planning -- 21.4 Procedure. 21.5 Pitfalls and Solutions-POULEZ and LAMPOON. |
| Record Nr. | UNINA-9910555251103321 |
Waksman Ron
|
||
| Hoboken, New Jersey : , : John Wiley & Sons, Inc., , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Transcatheter mitral valve therapies / / Ron Waksman, Toby Rogers
| Transcatheter mitral valve therapies / / Ron Waksman, Toby Rogers |
| Autore | Waksman Ron |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : John Wiley & Sons, Inc., , [2021] |
| Descrizione fisica | 1 online resource (403 pages) |
| Disciplina | 617.412 |
| Soggetto topico | Mitral valve - Surgery |
| ISBN |
1-119-76374-6
1-119-49065-0 1-119-49067-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Title Page -- Copyright Page -- Contents -- List of Contributors -- Introduction-The Mitral Book -- Chapter 1 The Pathology of Mitral Valve Disease -- 1.1 Introduction -- 1.2 General Anatomy of the Mitral Valve -- 1.2.1 Mitral Annulus -- 1.2.2 Leaflets -- 1.2.3 Chordae Tendineae and Papillary Muscles -- 1.2.4 Papillary Muscles and Left Ventricle -- 1.3 Pathology of Mitral Valve -- 1.3.1 Mitral Valve Stenosis -- 1.3.2 Aging Changes and Mitral Annulus Calcification (MAC) -- 1.3.3 Acute Mitral Regurgitation -- 1.3.4 Chronic Mitral Regurgitation -- 1.3.5 Degenerative MR -- Myxomatous Degeneration of the Mitral Valve -- 1.3.6 Functional MR -- References -- Chapter 2 The Importance of Minimally Invasive Approaches for Mitral Valve Repair -- 2.1 Introduction to Minimally Invasive Mitral Valve Surgery -- 2.2 The Importance of MICS MVS -- 2.3 Patient Selection -- 2.4 Surgical Setup-Fibrillating Heart MVS -- 2.5 Alternatives for Cannulation -- 2.6 Alternatives to Myocardial Protection -- 2.7 Mitral Valve Repair -- 2.8 Outcomes -- 2.9 Initiating Minimally Invasive Mitral Valve Repair Program -- 2.10 Conclusion -- References -- Chapter 3 When to Intervene-Should Surgical Guidelines Apply to Transcatheter Techniques in Treating Mitral Regurgitation? -- 3.1 Introduction -- 3.2 Primary MR -- 3.2.1 Current Guideline Recommendations -- 3.2.2 Transcatheter Therapies-New Guideline Applications? -- 3.3 Secondary MR -- 3.3.1 Current Guideline Recommendations -- 3.4 Conclusions -- References -- Chapter 4 Transcatheter Mitral Valve Therapies: A Three-Dimensional Echocardiographic View -- 4.1 Introduction -- 4.1.1 Mitral Valve Anatomy -- 4.1.2 Mitral Valve Structure and Function -- 4.1.3 Mitral Regurgitation Severity -- 4.1.4 Diagnosis of MR Severity: Proximal Isovelocity Surface Area Method -- 4.1.5 Diagnosis of MR Severity: Vena Contracta Method.
4.1.6 Primary and Secondary MR -- 4.1.7 Mitral Regurgitation and Cardiovascular Death and Morbidity -- 4.1.8 Screening for MitraClip Suitability -- 4.1.9 MitraClip Procedure Guidance -- 4.1.10 Transseptal Puncture -- 4.1.11 MitraClip Delivery Guidance -- 4.1.12 Adequacy of MitraClip Implantation Assessment -- 4.1.13 Other Technologies -- 4.2 Conclusions -- References -- Chapter 5 CMR Assessment of Mitral Regurgitation -- 5.1 Introduction -- 5.2 Pulse Sequences Used in CMR -- 5.2.1 Cine Imaging -- 5.2.2 Phase Contrast Imaging -- 5.3 Assessment of MR Severity -- 5.3.1 Qualitative Assessment -- 5.3.2 Quantitative Assessment -- 5.3.3 Technical Considerations for the Quantitative Assessment of MR by CMR -- 5.4 Identification of MR Etiology -- 5.4.1 Primary MR -- 5.4.2 Secondary MR -- 5.5 The Role of CMR Assessment of MR in Clinical Practice -- 5.6 Conclusions -- References -- Chapter 6 CT Planning for TMVR and Predicting LVOT Obstruction -- 6.1 Introduction -- 6.2 History of Imaging for Mitral Valve Disease -- 6.2.1 TAVR CT Planning -- 6.2.2 Surgical and Transcatheter Mitral Interventions -- 6.3 Concept of Aortic and Mitral Valve Technology Development -- 6.4 Basics of CT Imaging Acquisition -- 6.5 Definition of Mitral Valve and TMVR device Landing Zone -- 6.6 Definition of LVOT -- 6.7 CT Methods for Neo-LVOT prediction modeling -- 6.8 CT Validation of Neo-LVOT Prediction Modeling Post-TMVR -- 6.9 Correlation Between Pre- and Post-TMVR CT Neo-LVOT Prediction Modeling -- 6.10 What Else Has CT Planning for TMVR Taught Us? -- Acknowledgments -- References -- Chapter 7 General Principles and State-of-the-Art Echocardiographic Evaluation of the Mitral Valve -- 7.1 Introduction -- 7.2 Mechanism and Etiology of Chronic MR -- 7.2.1 Transthoracic Echocardiography -- 7.2.2.1 Color Flow Doppler -- 7.2.2 Qualitative Assessment -- 7.2.2.1 Color Flow Doppler. 7.3 Continuous Wave (CW) Density Jet -- 7.3.1 Semi-Quantitative Assessment -- 7.3.1.1 VC Width -- 7.4 Pulmonary Vein Flow/Mitral Inflow -- 7.4.1 Quantitative Assessment -- 7.5 Selection of Best Candidates for Interventions of the Mitral Valve -- 7.5.1 Echocardiographic Criteria of COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation) Trial -- References -- Chapter 8 Intraprocedural Echocardiography for MitraClip -- 8.1 Introduction -- 8.2 Pre-Procedure Evaluation -- 8.3 Importance of the Baseline Study - TEE -- 8.4 The Transseptal Puncture -- 8.5 Guiding MitraClip System to Mitral Valve -- 8.6 Intraprocedural Guidance of Clip within Mitral Valve and Leaflets -- 8.7 Post-Clip-Deployment Assessment of Mitral Valve Function -- 8.8 Assessment of Complications and Iatrogenic ASD -- References -- Chapter 9 Intraprocedural Echocardiography for Transcatheter Mitral Valve Replacement -- 9.1 Introduction -- 9.2 Baseline Mitral Valve Assessment -- 9.3 Access to the Left Atrium, Left Ventricle, and Mitral Valve -- 9.4 Predeployment and Deployment Monitoring -- 9.5 Postdeployment Evaluation -- References -- Chapter 10 Transcatheter Repair: MitraClip for Degenerative Mitral Regurgitation -- 10.1 Surgery for Degenerative Mitral Regurgitation -- 10.2 Evidence Base for MitraClip -- 10.3 Challenges for the MitraClip Procedure -- 10.4 Evaluation of MitraClip for Less than Prohibitive-Risk DMR Patients -- 10.5 Future Directions for MitraClip and Alternative Approaches for Leaflet Repair -- 10.6 Summary -- References -- Chapter 11 MitraClip™ for Secondary Mitral Regurgitation -- 11.1 Introduction -- 11.2 European and US Clinical Practice Guidelines -- 11.3 The MitraClip System -- 11.4 MitraClip Preprocedural Planning -- 11.5 Surgical Outcomes Data. 11.6 The COAPT and MITRA-FR Trials -- 11.7 Summary and Conclusions -- References -- Chapter 12 The Edwards PASCAL Transcatheter Valve Repair System -- 12.1 Introduction -- 12.2 The Edwards PASCAL™ Transcatheter Valve Repair System -- 12.3 Implantation Procedure -- 12.4 Compassionate-Use and Early Feasibility Data -- 12.5 Future Developments -- References -- Chapter 13 The Development of a Novel Percutaneous Treatment for Secondary Mitral Regurgitation-The Carillon® Mitral Contour System® -- 13.1 Introduction -- 13.2 REDUCE-FMR -- 13.3 The CARILLON Trial -- 13.4 Summary -- References -- Chapter 14 A Fully Percutaneous Mitral Ring: The Cardioband System -- 14.1 Introduction -- 14.2 Mitral Annulus Anatomy -- 14.3 Pathophysiological Role of the Mitral Annulus in Mitral Regurgitation -- 14.3.1 Mitral Annulus in FMR -- 14.3.2 Mitral Annulus in DMR -- 14.4 Surgical Annuloplasty in Mitral Regurgitation -- 14.5 The Cardioband System: Description of the Device -- 14.6 Procedural Planning -- 14.7 Clinical Studies -- 14.8 Possible Complications Related to the Implantation of Cardioband -- 14.9 Recurrence of Mitral Regurgitation Following Cardioband Implantation -- 14.10 Cardioband in Combination with Other Devices -- 14.11 Conclusions -- References -- Chapter 15 Transcatheter Mitral Cerclage Annuloplasty -- 15.1 Introduction -- 15.2 Cerclage Anatomy and Function -- 15.3 Limitations of Coronary Sinus Annuloplasty -- 15.4 Cerclage Annuloplasty Device -- 15.5 The Cerclage Procedure -- 15.6 Preclinical Experiments -- 15.7 Initial Human Experience -- 15.8 Future Directions -- 15.9 Summary -- Competing Interests -- References -- Chapter 16 The Transapical Off-Pump Mitral Valve Repair with the NeoChord Implantation (TOP-MINI) -- 16.1 Introduction -- 16.2 Technology -- 16.3 Patient Selection -- 16.4 Procedure -- 16.5 Echocardiographic Guidance -- 16.6 Examples. 16.6.1 Ideal Anatomy -- 16.6.2 Acceptable Anatomy -- 16.6.3 Challenging Anatomy -- 16.6.4 Data -- 16.7 Conclusion -- References -- Chapter 17 AltaValve™-A Transcatheter Mitral Valve Regurgitation Treatment Technology -- 17.1 Clinical Need -- 17.2 Device Description -- 17.2.1 Principle of Operation -- 17.2.2 Device Construction -- 17.2.2.1 Stent -- 17.2.2.2 Stent Cap -- 17.2.2.3 Tissue Valve -- 17.2.2.4 Fabric Skirts and Sutures -- 17.2.3 Delivery Systems -- 17.3 Anatomical Imaging and Sizing -- 17.4 Preclinical and Clinical Experience -- 17.4.1 Animal Studies -- 17.5 Human Clinical Experience -- 17.6 Summary -- References -- Chapter 18 The ARTO Transcatheter Mitral Valve Repair System -- 18.1 Device Description -- 18.2 Procedural Details -- 18.3 Clinical Experience with the ARTO System -- 18.4 Unique Features of the ARTO System -- References -- Chapter 19 Transcatheter Mitral Annuloplasty: The Millipede Device -- 19.1 Background -- 19.2 The Millipede Device -- 19.3 Millipede Implantation Procedure -- 19.4 Surgical Millipede Implants -- 19.5 Millipede Clinical Results -- 19.6 Clinical Implications -- 19.7 Summary -- Author Disclosures -- References -- Chapter 20 Transapical and Transseptal Access for Transcatheter Mitral Valve Replacement: Techniques and Devices -- 20.1 Introduction -- 20.2 Transapical Approach -- 20.2.1 Technique -- 20.2.2 Devices in Active Clinical Trial Phase -- 20.2.2.1 Tendyne -- 20.2.2.2 Intrepid -- 20.2.2.3 CardiAQ -- 20.2.2.4 TIARA -- 20.2.2.5 HighLife -- 20.3 Transseptal Approach -- 20.3.1 Technique -- 20.3.2 Devices in Active Clinical Trial Phase -- 20.3.2.1 Sapien M3 -- 20.3.2.2 EVOQUE -- 20.3.2.3 Caisson -- 20.4 Conclusions -- References -- Chapter 21 Mitral Valve-in-Valve and Valve-in-Ring Therapies -- 21.1 Overview -- 21.2 Evidence -- 21.3 Procedure Planning -- 21.4 Procedure. 21.5 Pitfalls and Solutions-POULEZ and LAMPOON. |
| Record Nr. | UNINA-9910678024003321 |
|
Waksman Ron
|
||
| Hoboken, New Jersey : , : John Wiley & Sons, Inc., , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||